Researcher
Katrien De Wolf
- Disciplines:Palliative care and end-of-life care, Laboratory medicine, Other translational sciences, Morphological sciences, Regenerative medicine, Oncology, Nursing, Other clinical sciences, Other basic sciences, Other paramedical sciences, Other health sciences, Other medical and health sciences
Affiliations
- Department of Radiation oncology and experimental cancer research (Department)
Member
From15 Jul 2014 → 24 Sep 2017
Publications
1 - 8 of 8
- Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma(2018)
Authors: Nora Sundahl, Katrien De Wolf, Vibeke Kruse, Annabel Meireson, Dries Reynders, Els Goetghebeur, Mireille Van Gele, Reinhart Speeckaert, Benjamin Hennart, Lieve Brochez, et al.
Pages: 906 - 915 - A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response(2017)
Authors: Katrien De Wolf, VIBEKE KRUSE, Nora Sundahl, Mireille Van Gele, Ines Chevolet, Reinhart Speeckaert, Lieve Brochez, Piet Ost
- Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect(2015)Volume: 26
Authors: Katrien De Wolf, Piet Ost, VIBEKE KRUSE, Lieve Brochez, Ines Chevolet
Pages: 7 - 7 - Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (18F-FDG-PET) in the treatment of bone metastases : results from a 3-arm randomized phase II trial
Authors: Dieter Berwouts, Katrien De Wolf, Wilfried De Neve, Ana Maria Luiza Olteanu, Bieke Lambert, Bruno Speleers, Indira Madani, Piet Ost
Pages: 124 - 132 - A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response
Authors: Nora Sundahl, Katrien De Wolf, Daan De Maeseneer, Annabel Meireson, Els Goetghebeur, Pieter De Visschere, Dries Reynders, Mireille Van Gele, Lieve Brochez, Piet Ost
- The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy
Authors: Katrien De Wolf, Karim Vermaelen, Piet Ost
- Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial
Authors: Katrien De Wolf, Karim Vermaelen, Nora Sundahl, Lizzy De Lobel, Els Goetghebeur, Gert De Meerleer, Nicolaas Lumen, Daan De Maeseneer, Piet Ost
- Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: a 3-arm randomized phase II trial
Authors: Dieter Berwouts, Katrien De Wolf, Bieke Lambert, Wilfried De Neve, Lizzy De Lobel, Els Goetghebeur, Bruno Speleers, Ana Maria Luiza Olteanu, Indira Madani, Piet Ost
Pages: 272 - 278